Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization

Victoria A. Roberts, Jon Stewart, Stephen Benkovic, Elizabeth D. Getzoff

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

To probe the mechanism of the catalytic antibody NPN43C9, we have constructed a three-dimensional model of the NPN43C9 variable region using our antibody structural database (ASD), which takes maximal advantage of immunoglobulin sequence and structural information. The ASD contains separately superimposed variable light and variable heavy chains, which reveal not only conserved backbone structure, but also structurally conserved side-chain conformations. The NPN43C9 model revealed that the guanidinium group of light chain Arg L96 was positioned at the bottom of the antigen binding site and formed a salt bridge with the antigen’s phosphonamidate group, which mimics the negatively charged, tetrahedral transition states in the hydrolysis reaction. Thus, the model predicts both binding and catalytic functions for Arg L96, which previously had not been implicated in either. First, Arg L96 should enhance antigen binding by electrostatically complementing the negative charge of the antigen, which is buried upon complex formation. Second, Arg L96 should promote catalysis by electrostatically stabilizing the negatively charged transition states formed during catalysis. These hypotheses were tested experimentally by design and characterization of the R-L96-Q mutant, in which Arg L96 was replaced with Gln by site-directed mutagenesis. As predicted, antigen binding in the R-L96-Q mutant was decreased relative to that in the parent NPN43C9 antibody, but binding of antigen fragments lacking the phosphonamidate group was retained. In addition, the R-L96-Q mutant had no detectable esterase activity. Thus, the computational model and experimental results together suggest a mechanism by which the catalytic antibody NPN43C9 stabilizes high-energy transition states during catalysis.

Original languageEnglish (US)
Pages (from-to)1098-1116
Number of pages19
JournalJournal of Molecular Biology
Volume235
Issue number3
DOIs
StatePublished - Jan 20 1994

Fingerprint

Catalytic Antibodies
Mutagenesis
Arginine
Antigens
Catalysis
Antibodies
Databases
Light
Guanidine
Esterases
Site-Directed Mutagenesis
Immunoglobulins
Hydrolysis
Theoretical Models
Salts
Binding Sites

All Science Journal Classification (ASJC) codes

  • Molecular Biology

Cite this

Roberts, Victoria A. ; Stewart, Jon ; Benkovic, Stephen ; Getzoff, Elizabeth D. / Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization. In: Journal of Molecular Biology. 1994 ; Vol. 235, No. 3. pp. 1098-1116.
@article{d6f96ee49ab64ca28bade1f12feb6821,
title = "Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization",
abstract = "To probe the mechanism of the catalytic antibody NPN43C9, we have constructed a three-dimensional model of the NPN43C9 variable region using our antibody structural database (ASD), which takes maximal advantage of immunoglobulin sequence and structural information. The ASD contains separately superimposed variable light and variable heavy chains, which reveal not only conserved backbone structure, but also structurally conserved side-chain conformations. The NPN43C9 model revealed that the guanidinium group of light chain Arg L96 was positioned at the bottom of the antigen binding site and formed a salt bridge with the antigen’s phosphonamidate group, which mimics the negatively charged, tetrahedral transition states in the hydrolysis reaction. Thus, the model predicts both binding and catalytic functions for Arg L96, which previously had not been implicated in either. First, Arg L96 should enhance antigen binding by electrostatically complementing the negative charge of the antigen, which is buried upon complex formation. Second, Arg L96 should promote catalysis by electrostatically stabilizing the negatively charged transition states formed during catalysis. These hypotheses were tested experimentally by design and characterization of the R-L96-Q mutant, in which Arg L96 was replaced with Gln by site-directed mutagenesis. As predicted, antigen binding in the R-L96-Q mutant was decreased relative to that in the parent NPN43C9 antibody, but binding of antigen fragments lacking the phosphonamidate group was retained. In addition, the R-L96-Q mutant had no detectable esterase activity. Thus, the computational model and experimental results together suggest a mechanism by which the catalytic antibody NPN43C9 stabilizes high-energy transition states during catalysis.",
author = "Roberts, {Victoria A.} and Jon Stewart and Stephen Benkovic and Getzoff, {Elizabeth D.}",
year = "1994",
month = "1",
day = "20",
doi = "10.1006/jmbi.1994.1060",
language = "English (US)",
volume = "235",
pages = "1098--1116",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "3",

}

Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization. / Roberts, Victoria A.; Stewart, Jon; Benkovic, Stephen; Getzoff, Elizabeth D.

In: Journal of Molecular Biology, Vol. 235, No. 3, 20.01.1994, p. 1098-1116.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization

AU - Roberts, Victoria A.

AU - Stewart, Jon

AU - Benkovic, Stephen

AU - Getzoff, Elizabeth D.

PY - 1994/1/20

Y1 - 1994/1/20

N2 - To probe the mechanism of the catalytic antibody NPN43C9, we have constructed a three-dimensional model of the NPN43C9 variable region using our antibody structural database (ASD), which takes maximal advantage of immunoglobulin sequence and structural information. The ASD contains separately superimposed variable light and variable heavy chains, which reveal not only conserved backbone structure, but also structurally conserved side-chain conformations. The NPN43C9 model revealed that the guanidinium group of light chain Arg L96 was positioned at the bottom of the antigen binding site and formed a salt bridge with the antigen’s phosphonamidate group, which mimics the negatively charged, tetrahedral transition states in the hydrolysis reaction. Thus, the model predicts both binding and catalytic functions for Arg L96, which previously had not been implicated in either. First, Arg L96 should enhance antigen binding by electrostatically complementing the negative charge of the antigen, which is buried upon complex formation. Second, Arg L96 should promote catalysis by electrostatically stabilizing the negatively charged transition states formed during catalysis. These hypotheses were tested experimentally by design and characterization of the R-L96-Q mutant, in which Arg L96 was replaced with Gln by site-directed mutagenesis. As predicted, antigen binding in the R-L96-Q mutant was decreased relative to that in the parent NPN43C9 antibody, but binding of antigen fragments lacking the phosphonamidate group was retained. In addition, the R-L96-Q mutant had no detectable esterase activity. Thus, the computational model and experimental results together suggest a mechanism by which the catalytic antibody NPN43C9 stabilizes high-energy transition states during catalysis.

AB - To probe the mechanism of the catalytic antibody NPN43C9, we have constructed a three-dimensional model of the NPN43C9 variable region using our antibody structural database (ASD), which takes maximal advantage of immunoglobulin sequence and structural information. The ASD contains separately superimposed variable light and variable heavy chains, which reveal not only conserved backbone structure, but also structurally conserved side-chain conformations. The NPN43C9 model revealed that the guanidinium group of light chain Arg L96 was positioned at the bottom of the antigen binding site and formed a salt bridge with the antigen’s phosphonamidate group, which mimics the negatively charged, tetrahedral transition states in the hydrolysis reaction. Thus, the model predicts both binding and catalytic functions for Arg L96, which previously had not been implicated in either. First, Arg L96 should enhance antigen binding by electrostatically complementing the negative charge of the antigen, which is buried upon complex formation. Second, Arg L96 should promote catalysis by electrostatically stabilizing the negatively charged transition states formed during catalysis. These hypotheses were tested experimentally by design and characterization of the R-L96-Q mutant, in which Arg L96 was replaced with Gln by site-directed mutagenesis. As predicted, antigen binding in the R-L96-Q mutant was decreased relative to that in the parent NPN43C9 antibody, but binding of antigen fragments lacking the phosphonamidate group was retained. In addition, the R-L96-Q mutant had no detectable esterase activity. Thus, the computational model and experimental results together suggest a mechanism by which the catalytic antibody NPN43C9 stabilizes high-energy transition states during catalysis.

UR - http://www.scopus.com/inward/record.url?scp=0028013654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028013654&partnerID=8YFLogxK

U2 - 10.1006/jmbi.1994.1060

DO - 10.1006/jmbi.1994.1060

M3 - Article

VL - 235

SP - 1098

EP - 1116

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 3

ER -